Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 102651-102700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04367805
COVID-19 Infection in Patients With Hepatocellular Carcinoma
N/A
Active, not recruiting
23 participants
Started: Apr 27, 2020 · Completed: Oct 31, 2024
2 conditions
17 sponsors
1 location
NCT03976180
High-flow Oxygen for Vaso-occlusive Pain Crisis
NA
Recruiting
350 participants
Started: Apr 27, 2020 · Completed: Nov 27, 2025
1 condition
3 sponsors
1 location
NCT04356235
Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques
N/A
Recruiting
528 participants
Started: Apr 27, 2020 · Completed: Apr 10, 2027
3 conditions
1 sponsor
1 location
NCT04093466
A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
PHASE1
Recruiting
126 participants
Started: Apr 27, 2020 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT04958720
Spanish Registry of Esophagogastric Cancer
N/A
Recruiting
10,000 participants
Started: Apr 27, 2020 · Completed: Dec 1, 2035
2 conditions
1 sponsor
38 locations
NCT04370119
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
N/A
Active, not recruiting
1,092 participants
Started: Apr 27, 2020 · Completed: May 31, 2025
1 condition
3 sponsors
1 location
NCT04712812
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
N/A
Recruiting
700 participants
Started: Apr 27, 2020 · Completed: Apr 26, 2026
11 conditions
1 sponsor
1 location
NCT06184789
Multiparametric Protocol for Assessment of Intraprocedural Result of MITRACLIP Procedure
N/A
Recruiting
80 participants
Started: Apr 27, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04414865
VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
N/A
Recruiting
100 participants
Started: Apr 26, 2020 · Completed: Dec 30, 2027
1 condition
1 sponsor
2 locations
NCT04264702
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
N/A
Active, not recruiting
1,788 participants
Started: Apr 24, 2020 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT04378023
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.
N/A
Recruiting
34 participants
Started: Apr 24, 2020 · Completed: Jun 1, 2027
1 condition
1 sponsor
1 location
NCT04340115
Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets
N/A
Recruiting
1,000 participants
Started: Apr 24, 2020 · Completed: Aug 31, 2025
1 condition
1 sponsor
1004 locations
NCT04291105
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
PHASE2
Recruiting
87 participants
Started: Apr 24, 2020 · Completed: Dec 31, 2025
3 conditions
2 sponsors
27 locations
NCT04130854
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
PHASE2
Active, not recruiting
58 participants
Started: Apr 24, 2020 · Completed: Dec 5, 2025
1 condition
2 sponsors
4 locations
NCT04058470
Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma
PHASE1/PHASE2
Recruiting
140 participants
Started: Apr 24, 2020 · Completed: Dec 30, 2025
6 conditions
1 sponsor
1 location
NCT03992456
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
PHASE2
Active, not recruiting
12 participants
Started: Apr 24, 2020 · Completed: Oct 7, 2024
30 conditions
2 sponsors
18 locations
NCT05100992
Progress Bifurcation Global Registry
N/A
Recruiting
4,000 participants
Started: Apr 23, 2020 · Completed: Jan 31, 2030
2 conditions
1 sponsor
1 location
NCT04375267
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours
PHASE1
Active, not recruiting
18 participants
Started: Apr 23, 2020 · Completed: Jun 30, 2024
4 conditions
2 sponsors
1 location
NCT04344262
Small Doses Muscle Relaxant in General Anesthesia
NA
Recruiting
60 participants
Started: Apr 22, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04292145
Effectiveness of Relaxation Techniques
NA
Recruiting
100 participants
Started: Apr 22, 2020 · Completed: Dec 22, 2024
1 condition
1 sponsor
1 location
NCT05074901
Virtual Agents-based Digital Interventions to Improve Health
NA
Recruiting
20,000 participants
Started: Apr 22, 2020 · Completed: Dec 31, 2027
5 conditions
1 sponsor
1 location
NCT03934567
A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
PHASE2
Active, not recruiting
87 participants
Started: Apr 22, 2020 · Completed: Oct 30, 2025
1 condition
1 sponsor
26 locations
NCT04214288
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
PHASE2
Active, not recruiting
240 participants
Started: Apr 22, 2020 · Completed: Mar 17, 2026
1 condition
1 sponsor
91 locations
NCT06419426
Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)
N/A
Active, not recruiting
2,000 participants
Started: Apr 22, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
25 locations
NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
260 participants
Started: Apr 22, 2020 · Completed: Aug 31, 2026
4 conditions
2 sponsors
21 locations
NCT02989948
Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA
NA
Active, not recruiting
38 participants
Started: Apr 22, 2020 · Completed: Dec 31, 2031
1 condition
1 sponsor
1 location
NCT04366999
Effectiveness of Bariatric Surgery for NAFLD/NASH
N/A
Recruiting
320 participants
Started: Apr 21, 2020 · Completed: Dec 31, 2026
3 conditions
11 sponsors
1 location
NCT04281641
Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
NA
Recruiting
94 participants
Started: Apr 21, 2020 · Completed: Apr 30, 2030
1 condition
1 sponsor
1 location
NCT06793111
Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)
N/A
Recruiting
300 participants
Started: Apr 21, 2020 · Completed: Dec 31, 2025
1 condition
5 sponsors
5 locations
NCT05747404
The FUnctional TricUspid REgurgitation by 3D EChocardiography Cooperative Study
N/A
Recruiting
1,500 participants
Started: Apr 21, 2020 · Completed: Apr 21, 2027
2 conditions
1 sponsor
4 locations
NCT04362150
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
N/A
Recruiting
800 participants
Started: Apr 21, 2020 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT04003922
Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term
N/A
Recruiting
40 participants
Started: Apr 21, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
16 locations
NCT04388605
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
N/A
Active, not recruiting
7,965 participants
Started: Apr 21, 2020 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT04280822
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
PHASE3
Recruiting
400 participants
Started: Apr 21, 2020 · Completed: Mar 2, 2028
4 conditions
1 sponsor
1 location
NCT04343885
In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
PHASE2
Active, not recruiting
130 participants
Started: Apr 21, 2020 · Completed: Mar 31, 2026
1 condition
9 sponsors
12 locations
NCT04788914
lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
NA
Recruiting
180 participants
Started: Apr 21, 2020 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT04810585
Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer
PHASE4
Recruiting
153 participants
Started: Apr 20, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT04687475
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
NA
Active, not recruiting
10 participants
Started: Apr 20, 2020 · Completed: Jun 1, 2026
2 conditions
1 sponsor
1 location
NCT04358107
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
N/A
Active, not recruiting
1,000 participants
Started: Apr 20, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06420687
GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices
NA
Active, not recruiting
45 participants
Started: Apr 20, 2020 · Completed: Sep 30, 2025
4 conditions
2 sponsors
1 location
NCT04393649
First Level Socio-geriatric Evaluation: ESOGER Databank
N/A
Active, not recruiting
20,000 participants
Started: Apr 20, 2020 · Completed: Apr 19, 2027
4 conditions
1 sponsor
1 location
NCT04355195
Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2)
N/A
Recruiting
18,100 participants
Started: Apr 20, 2020 · Completed: Jun 30, 2029
1 condition
2 sponsors
2 locations
NCT04248569
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
PHASE1
Recruiting
56 participants
Started: Apr 20, 2020 · Completed: Mar 1, 2034
1 condition
2 sponsors
1 location
NCT04354324
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
NA
Recruiting
254 participants
Started: Apr 20, 2020 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT03532295
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PHASE2
Active, not recruiting
51 participants
Started: Apr 20, 2020 · Completed: Apr 25, 2026
2 conditions
2 sponsors
4 locations
NCT05278052
Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
PHASE3
Recruiting
190 participants
Started: Apr 20, 2020 · Completed: Apr 20, 2028
2 conditions
1 sponsor
1 location
NCT04797091
Kidney in Coronavirus Disease 2019 Registry
N/A
Recruiting
500 participants
Started: Apr 20, 2020 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT04375982
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
NA
Active, not recruiting
200 participants
Started: Apr 20, 2020 · Completed: Mar 31, 2024
3 conditions
1 sponsor
4 locations
NCT04307511
A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients
PHASE4
Recruiting
40 participants
Started: Apr 20, 2020 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT04349527
Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving Surgeries
N/A
Recruiting
242 participants
Started: Apr 18, 2020 · Completed: Apr 5, 2027
3 conditions
1 sponsor
1 location
Previous
1
More pages
2051
2052
2053
2054
2055
2056
2057
More pages
2369
Next